| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shuei Sugama, Yoshihiko Kakinum. Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: Possible pathogenetic loci for depression involved in Parkinson's disease. Neuroscience research. vol 111. 2016-12-29. PMID:27142317. |
parkinson's disease (pd) is a neurodegenerative disease characterized by loss of dopaminergic (da) neurons in the nigrostriatal and mesolimbic pathways including ventral tegmental area (vta). |
2016-12-29 |
2023-08-13 |
rat |
| Chuang-Hsin Chiu, I-Hsun Li, Shao-Ju Weng, Yuahn-Sieh Huang, Shinn-Chih Wu, Ta-Kai Chou, Wen-Sheng Huang, Mei-Hsiu Liao, Chyng-Yann Shiue, Cheng-Yi Cheng, Kuo-Hsing M. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts. Cell transplantation. vol 25. issue 2. 2016-12-13. PMID:25994923. |
parkinson's disease (pd) is a neurodegenerative disease characterized by a loss of dopaminergic neurons in the nigrostriatal pathway. |
2016-12-13 |
2023-08-13 |
human |
| Ikuko Miyazaki, Masato Asanum. Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's Disease. Current medicinal chemistry. vol 23. issue 7. 2016-11-10. PMID:26795196. |
pd is a progressive neurodegenerative disease with motor symptoms such as tremor, bradykinesia, rigidity and postural instability, that are based on selective loss of nigrostriatal dopaminergic neurons, and with non-motor symptoms such as orthostatic hypotension and constipation based on peripheral neurodegeneration. |
2016-11-10 |
2023-08-13 |
mouse |
| Kai Tao, Bao Wang, Dayun Feng, Wei Zhang, Fangfang Lu, Juan Lai, Lu Huang, Tiejian Nie, Qian Yan. Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress. Neuroscience bulletin. vol 32. issue 1. 2016-11-03. PMID:26762342. |
parkinson's disease (pd) is a neurodegenerative disease characterized by a persistent decline of dopaminergic (da) neurons in the substantia nigra pars compacta. |
2016-11-03 |
2023-08-13 |
Not clear |
| Qunli Cui, Xin Li, Hongcan Zh. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway. Molecular medicine reports. vol 13. issue 2. 2016-10-31. PMID:26648392. |
parkinson's disease (pd) is an age-related complex neurodegenerative disease that affects ≤ 80% of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2016-10-31 |
2023-08-13 |
rat |
| Lifei Xing, Dongtao Wang, Lihong Wang, Wenjie Lan, Suyue Pa. Differential proteomics analysis of mononuclear cells in cerebrospinal fluid of Parkinson's disease. International journal of clinical and experimental pathology. vol 8. issue 11. 2016-10-24. PMID:26823915. |
parkinson's disease (pd) is one common neurodegenerative disease featured with degeneration of dopaminergic neurons in substantia nigra. |
2016-10-24 |
2023-08-13 |
Not clear |
| Venissa Machado, Tanja Zöller, Abdelraheim Attaai, Björn Spitta. Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice. International journal of molecular sciences. vol 17. issue 2. 2016-10-19. PMID:26821015. |
parkinson's disease (pd) is a neurodegenerative disease characterised by histopathological and biochemical manifestations such as loss of midbrain dopaminergic (da) neurons and decrease in dopamine levels accompanied by a concomitant neuroinflammatory response in the affected brain regions. |
2016-10-19 |
2023-08-13 |
mouse |
| Mingming Li, Yu Zou, Qiqi Lu, Ning Tang, Alexis Heng, Intekhab Islam, Huei Jinn Tong, Gavin S Dawe, Tong Ca. Efficient derivation of dopaminergic neurons from SOX1⁻ floor plate cells under defined culture conditions. Journal of biomedical science. vol 23. 2016-10-14. PMID:26956435. |
parkinson's disease (pd) is a severe neurodegenerative disease associated with loss of dopaminergic neurons. |
2016-10-14 |
2023-08-13 |
human |
| Heather L Martin, Matteo Santoro, Sarah Mustafa, Gernot Riedel, John V Forrester, Peter Teisman. Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease. Glia. vol 64. issue 3. 2016-10-06. PMID:26511587. |
parkinson's disease (pd) is the second most common neurodegenerative disease and results from the loss of dopaminergic neurons of the nigrostriatal pathway. |
2016-10-06 |
2023-08-13 |
mouse |
| Yujeong Lee, Hye Jeong Chun, Kyung Moon Lee, Young-Suk Jung, Jaewon Le. Silibinin suppresses astroglial activation in a mouse model of acute Parkinson's disease by modulating the ERK and JNK signaling pathways. Brain research. vol 1627. 2016-08-17. PMID:26434409. |
parkinson's disease (pd) is the second-most common neurodegenerative disease after alzheimer's disease, and is characterized by dopaminergic neuronal loss in midbrain. |
2016-08-17 |
2023-08-13 |
mouse |
| Saori Tsujii, Mitsue Ishisaka, Hideaki Har. Modulation of endoplasmic reticulum stress in Parkinson's disease. European journal of pharmacology. vol 765. 2016-08-01. PMID:26297973. |
parkinson's disease is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra in the midbrain. |
2016-08-01 |
2023-08-13 |
Not clear |
| Jun Wang, Can He, Wang-Yang Wu, Feng Chen, Yang-Yang Wu, Wei-Zu Li, Han-Qing Chen, Yan-Yan Yi. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease. Pharmacology, biochemistry, and behavior. vol 138. 2016-07-28. PMID:26394281. |
parkinson's disease (pd) is the second most common neurodegenerative disease, which is characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2016-07-28 |
2023-08-13 |
rat |
| Qingsong Hu, Guanghui Wan. Mitochondrial dysfunction in Parkinson's disease. Translational neurodegeneration. vol 5. 2016-07-25. PMID:27453777. |
parkinson's disease (pd) is the second most common neurodegenerative disease, which is characterized by loss of dopaminergic (da) neurons in the substantia nigra pars compacta and the formation of lewy bodies and lewy neurites in surviving da neurons in most cases. |
2016-07-25 |
2023-08-13 |
Not clear |
| Dorit Trudler, Yuval Nash, Dan Frenke. New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation. Journal of neural transmission (Vienna, Austria : 1996). vol 122. issue 10. 2016-07-06. PMID:25894287. |
the activation of glial cells in the brain is the first defense mechanism against pathological events in neurodegenerative diseases, and neuroinflammation is suggested to play an important role in pd disease progression leading to dopaminergic neuronal degeneration. |
2016-07-06 |
2023-08-13 |
Not clear |
| Yan-Hua Li, Qing He, Jie-zhong Yu, Chun-yun Liu, Ling Feng, Zhi Chai, Qing Wang, Hong-zhen Zhang, Guang-Xian Zhang, Bao-guo Xiao, Cun-gen M. Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson's disease model. Metabolic brain disease. vol 30. issue 5. 2016-06-24. PMID:26084861. |
parkinson's disease (pd) is a chronic neurodegenerative disease of the central nervous system (cns), characterized by a loss of dopaminergic neurons, which is thought to be caused by both genetic and environmental factors. |
2016-06-24 |
2023-08-13 |
Not clear |
| Yohei Mukai, Miho Murat. [Scans without Evidence of Dopamine Deficit (SWEDDs)]. Brain and nerve = Shinkei kenkyu no shinpo. vol 68. issue 1. 2016-05-02. PMID:26764301. |
dopamine transporter (dat) single-photon emission computed tomography (spect) and [18f]fluoro-l-dopa ([18f]dopa) positron emission tomography (pet) facilitate the investigation of dopaminergic hypofunction in neurodegenerative diseases. |
2016-05-02 |
2023-08-13 |
human |
| A Roy, S Mondal, J H Kordower, K Paha. Attenuation of microglial RANTES by NEMO-binding domain peptide inhibits the infiltration of CD8(+) T cells in the nigra of hemiparkinsonian monkey. Neuroscience. vol 302. 2016-04-26. PMID:25783477. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by the loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snpc). |
2016-04-26 |
2023-08-13 |
mouse |
| Sandy Stayte, Peggy Rentsch, Kong M Li, Bryce Visse. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease. PloS one. vol 10. issue 4. 2016-04-12. PMID:25902062. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by a significant loss of dopaminergic neurons within the substantia nigra pars compacta (snpc) and a subsequent loss of dopamine (da) within the striatum. |
2016-04-12 |
2023-08-13 |
mouse |
| Youssef Sari, Ashraf Khali. Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson's Disease. CNS & neurological disorders drug targets. vol 14. issue 6. 2016-03-23. PMID:25808895. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the loss of mainly the nigrostriatal dopaminergic neurons, which leads to motor dysfunction. |
2016-03-23 |
2023-08-13 |
Not clear |
| Javad Hami, Mehran Hosseini, Sekineh Shahi, Nassim Lotfi, Abolfazl Talebi, Mohammad Afsha. Effects of L-arginine pre-treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's diseases in Balb/c mice. Iranian journal of neurology. vol 14. issue 4. 2016-02-17. PMID:26885338. |
parkinson's disease (pd) is a common neurodegenerative disease resulting from the degeneration of dopaminergic (da) neurons in the substantia nigra pars compacta (snc). |
2016-02-17 |
2023-08-13 |
mouse |